ESTRO Multidisciplinary Management of Breast Cancer 2017

Previous Page

Next Page

Page Background

The majority of breast cancer patients do not benefit from adjuvant

chemotherapy

28

EBCTCG Lancet 2012;379:432-44. Walgren RA et al. J Clin Oncol 2005

© American Society of Clinical Oncology